Latest Shareholder Confidence News

Evolution Energy Minerals has successfully closed an oversubscribed rights issue, raising $1.45 million and topping up with an additional $300,000 placement to fund key graphite and copper projects.

OpenLearning Limited has agreed to convert $1 million of debt owed to its largest shareholder into equity at a premium, significantly increasing that shareholder's stake and reshaping the company's capital structure.

Cobram Estate Olives has secured $175 million through an institutional placement to accelerate its expansion in the US, aiming to increase its Californian olive groves to 3,600 hectares and boost olive oil production significantly by 2027.

Deterra Royalties Limited has updated its dividend announcement, confirming a fully franked ordinary dividend of AUD 0.13 per share for the half-year ending June 2025, alongside a recalculated Dividend Reinvestment Plan price.

Duxton Farms has reached a key milestone in its merger with four agricultural businesses, securing ASIC registration of scheme books and scheduling crucial shareholder meetings for October.

Torque Metals secures $2.8 million from early option exercises, boosting funding for its Paris Gold Project exploration in Western Australia.

Prospech Limited has announced a pro-rata renounceable entitlement offer aiming to raise up to $1.62 million to fund metallurgical testing and exploration at its Korsnäs rare earth elements project in Finland. The offer is partially underwritten and includes attaching options, reflecting the company’s ongoing development efforts and funding needs.

Pro-Pac Packaging is progressing a strategic review involving potential asset sales and liquidity support, with ASX trading suspension imminent pending financial disclosures.

Miramar Resources has secured $409,000 through a Share Purchase Plan to fund further exploration at its promising Gidji JV Gold Project, while advancing a strategic joint venture with Sumitomo at Bangemall.

ARB Corporation Limited has updated its dividend announcement, revealing pricing details for its Dividend Reinvestment Plan and Bonus Security Plan tied to a special fully franked AUD 0.50 dividend for FY2025.

Tryptamine Therapeutics reported a $5.33 million loss for FY25 while progressing key clinical trials of its psychedelic therapies and strengthening its leadership team. The company secured $6 million in funding and launched a world-first trial targeting Binge Eating Disorder.

AuKing Mining has successfully closed a two-tranche placement raising $1.17 million, with directors actively participating, to fund its Cloncurry Gold Project acquisition and reduce existing debt.